Beruflich Dokumente
Kultur Dokumente
Diabetes specialists
13. Clear guidelines should indicate when the diabetes
specialist team should become involved.
14. All hospitals should implement a Diabetes Inpatient
Specialist Nurse (DISN) service.
Peri-operative use of intravenous insulin
15. The term variable rate intravenous insulin infusion (VRIII)
should replace the ambiguous term sliding scale.
16. Patients with a planned short starvation period (no more
than one missed meal in total) should be managed by
modification of their usual diabetes medication, avoiding a
VRIII wherever possible.
17. Patients expected to miss more than one meal should
have a VRIII.
18. The recommended first choice substrate solution for a
VRIII is 0.45% sodium chloride with 5% glucose and either
0.15% potassium chloride (KCl) or 0.3% KCl.
19. Insulin should be prescribed according to National Patient
Safety Agency (NPSA) recommendations for safe use of
insulin.
Peri-operative blood glucose monitoring
20. Capillary blood glucose (CBG) levels should be monitored
and recorded at least hourly during the procedure and in the
immediate postoperative period.
21. Hospitals should have clear guidelines for the
management of blood glucose when it is outside the
acceptable range.
22. Training for blood glucose measurement and diabetes
management should be introduced for clinical staff caring for
patients with diabetes.
23.
The WHO surgical safety checklist bundle should be
No
1
Nursing Diagnose
Imbalanced
Nutrition: More
than Body
Requirements
related to intake
in excess of
activity
expenditures
Outcome
Nutrition
balance
between
needs and
intake
Intervention
Fear related to
insulin injection
Fear less or
discrease
Evaluation
Maintains ideal
body weight with
body mass index
less than 25
Demonstrates
self-injection of
insulin with
minimal fear
Hypoglycemia
identified and
treated
appropriately
inability to eat
Activity
Intolerance
related to poor
glucose control
Normal
Activity is
appears
Deficient
Knowledge
related to use of
oral
hypoglycemic
agents
Knowledge is
sufficient
hypoglycemia.
Assess patient for the signs and symptoms of
hypoglycemia.
Adrenergic (early symptoms) sweating, tremor,
pallor, tachycardia, palpitations, nervousness from
the release of adrenalin when blood glucose falls
rapidly
Neurologic (later symptoms) light-headedness,
headache, confusion, irritability, slurred speech,
lack of coordination, staggering gait from
depression of central nervous system as glucose
level progressively falls
Treat hypoglycemia promptly with 15 to 20 g of
fast-acting carbohydrates.
Encourage patient to carry a portable treatment for
hypoglycemia at all times.
Assess patient for cognitive or physical impairments
that may interfere with ability to accurately
administer insulin.
Between-meal snacks as well as extra food taken
before exercise should be encouraged to prevent
hypoglycemia.
Encourage patients to wear an identification
bracelet or card that may assist in prompt treatment
in a hypoglycemic emergency.
Encourage patient to carry a portable treatment for
hypoglycemia at all times.
Assess patient for cognitive or physical impairments
that may interfere with ability to accurately
administer insulin.
Between-meal snacks as well as extra food taken
before exercise should be encouraged to prevent
hypoglycemia.
Encourage patients to wear an identification
bracelet or card that may assist in prompt treatment
in a hypoglycemic emergency.
Advise patient to assess blood glucose level before
and after strenuous exercise.
Instruct patient to plan exercises on a regular basis
each day.
Encourage patient to eat a carbohydrate snack
before exercising to avoid hypoglycemia.
Advise patient that prolonged strenuous exercise
may require increased food at bedtime to avoid
nocturnal hypoglycemia.
Instruct patient to avoid exercise whenever blood
glucose levels exceed 250 mg/day and urine ketones
are present. Patient should contact health care
provider if levels remain elevated.
Counsel patient to inject insulin into the abdominal
site on days when arms or legs are exercised.
Exercises daily
Verbalizes
appropriate use
and action of oral
hypoglycemic
agents
sensation and
circulation to
lower extremities
Ineffective
Effective
Coping related to coping
chronic disease
and complex selfcare regimen
No skin
breakdown
Verbalizes initial
strategies for
coping with
diabetes
Rational: the peripheral circulation may be disturbed that puts patients at increased risk of damage to the skin / skin
irritation and infection.
5). Make changes to the position, effective coughing and encourage deep breathing.
Rational: memventilasi Assist in all areas and mobilize pulmonary secretions.
4. Activity Intolerance
Activity Intolerance Definition : Insufficient physiological or psychological energy to endure or complete required or
desired daily activities
Activity intolerance is related to generalized weakness and debilitation secondary to acute or chronic illness and
disease. This is especially apparent in elderly patients with a history of orthopedic, cardiopulmonary, diabetic, or
pulmonary- related problems. The aging process itself causes reduction in muscle strength and function, which can
impair the ability to maintain activity. Activity intolerance may also be related to factors such as obesity,
malnourishment, side effects of medications (e.g., Beta-blockers), or emotional states such as depression or lack of
confidence to exert one's self.
Nursing goals are to reduce the effects of inactivity, promote optimal physical activity, and assist the patient to
maintain a satisfactory lifestyle.
Related Factors:
Generalized weakness
Deconditioned state
Sedentary lifestyle
Insufficient sleep or rest periods
Depression or lack of motivation
Prolonged bed rest
Imposed activity restriction
Imbalance between oxygen supply and demand
Pain
Side effects of medications
Nursing Interventions for Activity Intolerance
1. Assess patient's level of mobility. This aids in defining what patient is capable of, which is necessary before
setting realistic goals.
2. Assess nutritional status. Adequate energy reserves are required for activity.
3. Assess potential for physical injury with activity. Injury may be related to falls or overexertion.
4. Assess patient's cardiopulmonary status before activity using the following measures:
Heart rate Heart rate should not increase more than 20 to 30 beats/min above resting with routine activities. This
number will change depending on the intensity of exercise the patient is attempting (e.g., climbing four flights of
stairs versus shoveling snow).
Orthostatic BP changes Elderly patients are more prone to drops in blood pressure with position changes.
Need for oxygen with increased activity Portable pulse oximetry can be used to assess for oxygen desaturation.
Supplemental oxygen may help compensate for the increased oxygen demands.
How Valsalva maneuver affects heart rate when patient moves in bed Valsalva maneuver, which requires breath
holding and bearing down, can cause bradycardia and related reduced cardiac output.
Assess need for ambulation aids: bracing, cane, walker, equipment modification for activities of daily living (ADLs).
Some aids may require more energy expenditure for patients who have reduced upper arm strength (e.g., walking
with crutches). Adequate assessment of energy requirements is indicated.
6. Determine patient's perception of causes of fatigue or activity intolerance. These may be temporary or
permanent, physical or psychological. Assessment guides treatment.
Monitor patient's sleep pattern and amount of sleep achieved over past few days. Difficulties sleeping need to be
addressed before activity progression can be achieved.
Fatigue
Nursing Diagnosis: Fatigue
May be related to
Decreased metabolic energy production
Altered body chemistry: insufficient insulin
Increased energy demands: hypermetabolic state/infection
Possibly evidenced by
Overwhelming lack of energy, inability to maintain usual routines, decreased performance, accidentprone
Impaired ability to concentrate, listlessness, disinterest in surroundings
Desired Outcomes
Verbalize increase in energy level.
Display improved ability to participate in desired activities.
Nursing Interventions
Rationale
Discuss with patient the need for activity. Plan schedule with
patient and identify activities that lead to fatigue.
Discuss ways of conserving energy while bathing, transferring, and Patient will be able to accomplish more with a decreased
so on.
expenditure of energy.
Increase patient participation in ADLs as tolerated.
Powerlessness
Nursing Diagnosis: Powerlessness
May be related to
Long-term/progressive illness that is not curable
Dependence on others
Possibly evidenced by
Reluctance to express true feelings; expressions of having no control/influence over situation
Rationale
Recognition that reactions are normal can help patient problem-solve and seek help as needed.
Diabetic control is a full-time job that serves as a constant reminder of both presence of disease
and threat to patients health/life.
Knowledge of individuals style helps determine needs for treatment goals. Patient whose locus
of control is internal usually looks at ways to gain control over own treatment program. Patient
who operates with an external locus of control wants to be cared for by others and may project
blame for circumstances onto external factors.
Constant energy and thought required for diabetic control often shifts the focus of a
relationship. Development of psychological concerns/visceral neuropathies affecting selfconcept (especially sexual role function) may add further stress.
Rationale
Provides a baseline from which to compare abnormal findings,
e.g., fever may affect mentation.
Desired Outcomes:
Identify interventions to prevent/reduce risk of infection.
Demonstrate techniques, lifestyle changes to prevent development of infection.
Nursing Interventions
Rationale
Patient may be admitted with infection, which could have precipitated the
ketoacidotic state, or may develop a nosocomial infection.
Provide conscientious skin care; gently massage bony Peripheral circulation may be impaired, placing patient at increased risk for skin
areas. Keep the skin dry, linens dry and wrinkle-free. irritation/breakdown and infection.
5. Knowledge Deficit
Goal: patient expressed understanding of the conditions, procedures and effects of the treatment process.
Expected outcomes:
Perform the necessary procedures and explain the rationale of an action.
MANAGEMENT
DIABETES MANAGEMENT
The main goal of diabetes treatment is to normalize insulin activity and blood glucose levels to reduce the development of
vascular and neuropathic complications.
Drugs for Treating Hyperglycemia
The drugs for treating type 2 diabetes fall into several categories:
1)Drugs that primarily stimulate insulin secretion by binding to the sulfonylurea receptor. Sulfonylureas remain the most
widely prescribed drugs for treating hyperglycemia. The meglitinide analog repaglinide and the D-phenylalanine derivative
nateglinide also bind the sulfonylurea receptor and stimulate insulin secretion.
2)Drugs that alter insulin action: Metformin works in the liver. The thiazolidinediones appear to have their main effect on
skeletal muscle and adipose tissue.
3)Drugs that principally affect absorption of glucose: The glucosidase inhibitors acarbose and miglitol are such currently
available drugs.
4) Drugs that mimic incretin effect or prolong incretin action: Exenatide and DPP 1V inhibitors fall into this category.
5) Other: Pramlintide lowers glucose by suppressing glucagon and slowing gastric emptying.
Insulin
Insulin is indicated for type 1 diabetes as well as for type 2 diabetic patients with insulinopenia whose hyperglycemia does
not respond to diet therapy either alone or combined with other hypoglycemic drugs.
Therefore, the therapeutic goal for diabetes management is to achieve normal blood glucose levels (euglycemia) without
hypoglycemia and without seriously disrupting the patients usual lifestyle and activity.
There are five components of diabetes management
Nutritional management
Exercise
Monitoring
Pharmacologic therapy
Education
Classification of Diabetes Mellitus
There are several different types of diabetes mellitus; they may differ in cause, clinical course, and treatment. The major
classifications of diabetes are:
Type 1 diabetes (insulin dependent diabetes mellitus) is caused by B-cell destruction, usually leading to absolute insulin
deficiency
a) Immune mediated
b) Idiopathic
Type 2 diabetes (previously referred to as non insulin dependent diabetes mellitus) ranges from those with predominant
insulin resistance associated with relative insulin deficiency, to those with a predominantly insulin secretory defect with
insulin resistance
Statistics
Diabetes affects 18% of people over the age of 65, and approximately 625,000 new cases of diabetes are
diagnosed annually in the general population. Conditions or situations known to exacerbate glucose/insulin
imbalance include (1) previously undiagnosed or newly diagnosed type 1 diabetes; (2) food intake in
excess of available insulin; (3) adolescence and puberty; (4) exercise in uncontrolled diabetes; and (5)
stress associated with illness, infection, trauma, or emotional distress. Type 1 diabetes can be complicated
by instability and diabetic ketoacidosis (DKA). DKA is a life-threatening emergency caused by a relative or
absolute deficiency of insulin.
PHARMACOLOGY MANAGEMENT
Drugs. 1997 Jun;53(6):1081-105.
Abstract
Lisinopril, like other ACE inhibitors, lowers blood pressure and preserves renal function in hypertensive patients
with non-insulin-dependent or insulin-dependent diabetes mellitus (NIDDM or IDDM) and early or overt
nephropathy, without adversely affecting glycaemic control or lipid profiles. On available evidence, renoprotective
effects appear to be greater with lisinopril than with comparator calcium channel blockers, diuretics and betablockers, despite similar antihypertensive efficacy. As shown by the EUCLID (EUrodiab Controlled trial of Lisinopril
in Insulin-Dependent Diabetes) trial, lisinopril is also renoprotective in normotensive patients with IDDM and
microalbuminuria. The effect in normotensive patients with normoalbuminuria was smaller than in those with
microalbuminuria, and no conclusions can yet be made about its use in patients with normoalbuminuria. In
complications other than nephropathy, lisinopril has shown some benefit. Progression to retinopathy was slowed
during 2 years' lisinopril therapy in the EUCLID study. Although not yet fully published, these results provide the
most convincing evidence to date for an effect of an ACE inhibitor in retinopathy. The drug may also improve
neurological function, but this finding is preliminary. Lastly, post hoc analysis of the GISSI-3 trial indicates that
lisinopril reduces 6-week mortality rates in diabetic patients when begun as early treatment after an acute
myocardial infarction. The tolerability profile of lisinopril is typical of ACE inhibitors and appears to be similar in
diabetic and nondiabetic individuals. Hypoglycaemia has occurred at a similar frequency with lisinopril and placebo,
as shown in the EUCLID trial. In addition, the GISSI-3 study indicates that the incidence of persistent hypotension
and renal dysfunction is increased with lisinopril in general, but the presence of diabetes does not appear to confer
additional risk of these events in diabetic patients with acute myocardial infarction receiving lisinopril. In summary,
lisinopril lowers blood pressure and produces a renoprotective effect in patients with IDDM and NIDDM without
detriment to glycaemic control or lipid profiles. Like other ACE inhibitors, lisinopril should thus be viewed as a firstline agent for reducing blood pressure and preventing or attenuating nephropathy in hypertensive diabetic patients
with IDDM or NIDDM and microalbuminuria or overt renal disease. The EUCLID study, using lisinopril, provides
new data supporting an additional place in managing normotensive patients with microalbuminuria and IDDM.
These findings, together with some evidence for an effect of lisinopril in delaying progression of retinopathy and in
reducing mortality, suggest a broader role for the drug in managing diabetic vascular complications.
MANAGEMENT